New Approaches to Chronic Hepatitis B | New England Journal of Medicine Skip to main content
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …

The immune system has crucial roles in cancer development and treatment. Whereas
adaptive immunity can prevent or constrain cancer through immunosurveillance, innate …

Hepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which
can cause liver disease and increased risk of hepatocellular carcinoma (HCC) in infected …

Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related death.
Although the burden of alcohol-and NASH-related HCC is growing, chronic viral hepatitis …

Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …

We sought to investigate the clinical profile (s) associated with the discontinuation of
lenvatinib (LEN) due to severe adverse events (DLSAE) in patients with unresectable …

Abstract The “macrotrabecular-massive”(MTM) pattern of hepatocellular carcinoma (HCC)
has been suggested to represent a distinct HCC subtype and is associated with specific …

BACKGROUND Reliable biomarkers of cirrhosis, hepatocellular carcinoma (HCC), or
progression of chronic liver diseases are missing. In this context, Golgi protein-73 (GP73) …

China has one of the highest incidence rates of hepatocellular carcinoma (HCC) in the
world. As most patients are diagnosed with advanced or unretractable HCC, systematic …